Candel Therapeutics Files 8-K
Ticker: CADL · Form: 8-K · Filed: Mar 27, 2025 · CIK: 1841387
Sentiment: neutral
Topics: 8-K, disclosure, financials
TL;DR
Candel Therapeutics dropped an 8-K on March 27th covering Reg FD, other events, and financials. Check it out.
AI Summary
Candel Therapeutics, Inc. filed an 8-K on March 27, 2025, reporting events as of March 26, 2025. The filing includes information related to Regulation FD Disclosure, Other Events, and Financial Statements and Exhibits. The company, incorporated in Delaware, is in the biological products sector.
Why It Matters
This 8-K filing provides updates on Candel Therapeutics' regulatory disclosures, other significant events, and financial statements, which are crucial for investors to understand the company's current status and potential impacts.
Risk Assessment
Risk Level: low — This filing is a routine 8-K reporting standard disclosures and financial information, not indicating any immediate material adverse events.
Key Players & Entities
- Candel Therapeutics, Inc. (company) — Registrant
- March 26, 2025 (date) — Earliest event reported
- March 27, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
- 001-40629 (identifier) — SEC file number
- 52-2214851 (identifier) — IRS Employer Identification No.
- 117 Kendrick St., Suite 450 Needham, MA 02494 (address) — Principal Executive Offices
FAQ
What is the primary purpose of this 8-K filing for Candel Therapeutics, Inc.?
The 8-K filing serves to report on Regulation FD Disclosure, Other Events, and Financial Statements and Exhibits as of March 26, 2025.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on March 26, 2025.
What is Candel Therapeutics, Inc.'s state of incorporation and SEC file number?
Candel Therapeutics, Inc. is incorporated in Delaware and has the SEC file number 001-40629.
Where are Candel Therapeutics, Inc.'s principal executive offices located?
The principal executive offices of Candel Therapeutics, Inc. are located at 117 Kendrick St., Suite 450 Needham, MA 02494.
What is the SIC code for Candel Therapeutics, Inc. and what industry does it represent?
The SIC code for Candel Therapeutics, Inc. is 2836, which represents Biological Products (No Diagnostic Substances).
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 27, 2025 regarding Candel Therapeutics, Inc. (CADL).